Ryohei Yoshida - Concepedia

Author

Ryohei Yoshida

Asahikawa Medical University ORCID

Also Known As

R. Yoshida, RYOHEI YOSHIDA, Ryohei YOSHIDA, Ryohei Yoshida

Publications

866

Citations

H-Index

Concepts

All Affiliations

Asahikawa Medical University Japanese Foundation For Cancer Research Brigham and Women's Hospital Sapporo Higashi Tokushukai Hospital Brown University

About

Ryohei Yoshida is an author at Asahikawa Medical University specializing in medicine, lung cancer, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	214
2	Cell Biology	4	4	203
3	Pathology	2	2	35
4	Health Sciences	1	1	24
5	Immunology	1	1	56

Ryohei Yoshida

Publications

822

Citations

H-Index

Page 1

	Year	Citations
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer Shunsuke Kitajima, Elena V. Ivanova, Sujuan Guo, Cancer Discovery	2018	489
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer Shunsuke Kitajima, Tetsuo Tani, Benjamin F. Springer, Cancer Cell MedicineMps1 InhibitionTumor SuppressorCancer BiologyCell Biology	2022	90
Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report Yoshitsugu Narumi, Ryohei Yoshida, Yoshinori Minami, BMC Cancer	2018	63
Tumor-Derived cGAMP Regulates Activation of the Vasculature Marco Campisi, Shriram K. Sundararaman, Sarah E. Shelton, Frontiers in Immunology ImmunologyImmunologic MechanismInnate ImmunityImmunotherapyTumor Biology	2020	56
Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer Ryohei Yoshida, Takaaki Sasaki, Yoshinori Minami, International Journal of Oncology Src SignalingCancer BiologyAnaplastic Lymphoma KinaseTumor BiologyReceptor Tyrosine Kinase	2017	33
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer Ryohei Yoshida, Maria Saigí, Tetsuo Tani, Cancer Research	2022	33
Response to Crizotinib Re-administration After Progression on Lorlatinib in a Patient With ALK-rearranged Non–small-cell Lung Cancer Jun Sakakibara‐Konishi, Hidenori Kitai, Yasuyuki Ikezawa, Clinical Lung Cancer Gene RearrangementTumor HeterogeneityMedicinePathologyCancer Cell Biology	2019	24
Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR Ryohei Yoshida, Takaaki Sasaki, Yasuhiro Umekage, BMC Cancer	2018	23
Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR Ryo Ariyasu, Ken Uchibori, Takaaki Sasaki, Cancer Science OncologyCancer DetectionMedicinePathologyDigital Droplet Pcr	2021	11

Page 1